http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104193603-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K2211-1007
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C46-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C46-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K11-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C46-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C50-28
filingDate 2014-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104193603-B
titleOfInvention Structure, preparation and application of aryl benzoquinone compound
abstract The invention relates to a structure, preparation method and partial properties of a compound. The novel compound has the appearance of claret-colored crystal, the melting point of 177-179 DEG C, the molecular formula of C24H24O8, and the chemical name of 2,6-bis(2,4,5-trimethoxyphenyl)cyclohexane-2,5-diene-1,4-dione, and has a structure shown in descriptions. A crystal of the compound belongs to an orthorhombic crystal system and has the space group of Pbca, a is equal to 17.499(9) angstroms, b is equal to 8.287(4) angstroms, c is equal to 29.962(15) angstroms, alpha is equal to beta, is equal to gamma and is equal to 90 degrees, V is equal to 4345(4) angstroms<3>, and Z is equal to 8. The compound is simple in preparation method, has very strong purple fluorescence at 370-400nm, and has inhibition activity to lung cancer A549 cells.
priorityDate 2014-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432359121
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4111
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8000
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452212
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4111
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450459896
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146645
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141288086
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916

Total number of triples: 43.